Verrica Pharmaceuticals Inc. Loss Contingency, New Claims Filed, Number
Verrica Pharmaceuticals Inc. (VRCA) reported Loss Contingency, New Claims Filed, Number of 0 claim for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2020-03-13
- Verrica Pharmaceuticals Inc. loss contingency, new claims filed, number for fiscal 2019 was 0.00 claim.
- Verrica Pharmaceuticals Inc. loss contingency, new claims filed, number for fiscal 2018 was 0.00 claim.
- Verrica Pharmaceuticals Inc. loss contingency, new claims filed, number for fiscal 2017 was 0.00 claim.
| Period end | Loss Contingency, New Claims Filed, Number 9 month | Loss Contingency, New Claims Filed, Number 12 month |
|---|---|---|
| 2019-12-31 | 0.00 claim 10-K · filed 2020-03-13 | |
| 2018-12-31 | 0.00 claim 10-K · filed 2020-03-13 | |
| 2018-09-30 | 0.00 claim 10-Q · filed 2018-11-07 | |
| 2017-12-31 | 0.00 claim 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |